» Articles » PMID: 19583975

Ondansetron Blocks LiCl-induced Conditioned Place Avoidance but Not Conditioned Taste/flavor Avoidance in Rats

Overview
Journal Physiol Behav
Date 2009 Jul 9
PMID 19583975
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The ability of an experimental agent to support conditioned taste/flavor avoidance (CT/FA) in rats often is interpreted as sufficient evidence that the agent produced a state of malaise or nausea. Paradoxically, however, CT/FA also is induced by certain drugs that support conditioned preferences in rats, suggesting that CT/FA is insufficient to reveal a negative hedonic state. The present study tested the hypothesis that the anti-nausea drug ondansetron (OND) would block the ability of nauseogenic lithium chloride (LiCl) to support conditioned place avoidance (CPA), without attenuating LiCl-induced CT/FA. After pre-treatment with either OND or vehicle, rats were conditioned with i.p. injection of 0.15 M LiCl containing 2% saccharin (LiCl+sac) on conditioning day 1, and with 0.15 M NaCl alone on conditioning day 2. Rats were confined to a distinct chamber of a CPA apparatus after each conditioning injection. In other rats, OND or vehicle pre-treatment was followed by NaCl+sac on conditioning day 1, and LiCl alone on day 2. Subsequent testing revealed that OND blocked the ability of LiCl to support CPA. Conversely, in the same rats, OND did not alter the ability of LiCl to condition avoidance of 0.2% sac solution during a 60 min bottle test. In a separate experiment, a sensitive 2-bottle choice test was used to confirm that OND pre-treatment does not reduce the ability of LiCl to support CT/FA. These results support the view that CPA is an additional useful tool to reveal the experience of malaise and nausea in rats, whereas CT/FA demonstrated in bottle intake tests is insufficient for this purpose.

Citing Articles

Evaluating proxies for motion sickness in rodent.

Zhang F, Xie X, Guo Z, Wang H, Li H, Wu K IBRO Neurosci Rep. 2024; 15:107-115.

PMID: 38204574 PMC: 10776324. DOI: 10.1016/j.ibneur.2023.06.006.


Maintenance of conditioned place avoidance induced by gastric malaise requires NMDA activity within the ventral hippocampus.

Hernandez-Matias A, Bermudez-Rattoni F, Osorio-Gomez D Learn Mem. 2021; 28(9):270-276.

PMID: 34400528 PMC: 8372560. DOI: 10.1101/lm.052720.120.


Amphetamine-induced activation of neurons within the rat nucleus of the solitary tract.

Edwards C, Strother J, Zheng H, Rinaman L Physiol Behav. 2019; 204:355-363.

PMID: 30831183 PMC: 6746333. DOI: 10.1016/j.physbeh.2019.02.040.


Expression and pharmacological modulation of visceral pain-induced conditioned place aversion in mice.

Bagdas D, Muldoon P, AlSharari S, Carroll F, Negus S, Damaj M Neuropharmacology. 2015; 102:236-43.

PMID: 26639043 PMC: 5574195. DOI: 10.1016/j.neuropharm.2015.11.024.


SIP30 is required for neuropathic pain-evoked aversion in rats.

Han M, Xiao X, Yang Y, Huang R, Cao H, Zhao Z J Neurosci. 2014; 34(2):346-55.

PMID: 24403136 PMC: 6608160. DOI: 10.1523/JNEUROSCI.3160-13.2014.

References
1.
Suzuki T, Ise Y, Mori T, Misawa M . Attenuation of mecamylamine-precipitated nicotine-withdrawal aversion by the 5-HT3 receptor antagonist ondansetron. Life Sci. 1997; 61(16):PL249-54. DOI: 10.1016/s0024-3205(97)00745-5. View

2.
Bradley R, Mistretta C . Intravascular taste in rats as demonstrated by conditioned aversion to sodium saccharin. J Comp Physiol Psychol. 1971; 75(2):186-9. DOI: 10.1037/h0030813. View

3.
Otto B, Riepl R, Klosterhalfen S, Enck P . Endocrine correlates of acute nausea and vomiting. Auton Neurosci. 2006; 129(1-2):17-21. DOI: 10.1016/j.autneu.2006.07.010. View

4.
Higgins G, Nguyen P, Joharchi N, Sellers E . Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal. Psychopharmacology (Berl). 1991; 105(3):322-8. DOI: 10.1007/BF02244425. View

5.
Dielenberg R, Arnold J, McGregor I . Low-dose midazolam attenuates predatory odor avoidance in rats. Pharmacol Biochem Behav. 1999; 62(2):197-201. DOI: 10.1016/s0091-3057(98)00064-1. View